LAMEA Needle-free Injection Systems Market Analysis (2017-2023)

LAMEA Needle-free Injection Systems Market Analysis (2017-2023)

  • November 2017 •
  • 114 pages •
  • Report ID: 5258058 •
  • Format: PDF
The LAMEA Needle-free Injection Systems Market would witness market growth of 18.2% CAGR during the forecast period (2017 – 2023). Needle free injection technology (NFIT) includes a wide range of drug delivery systems which are used to drive drugs through the skin using any of the forces such as Lorentz, Shock waves, pressure by gas or electrophoresis. The process propels the drug to pass through the skin, and virtually nullifies the use of hypodermic needles. The technology is highly beneficial in the pharma industry and also it is widely popular in the developing countries, as it is used in mass immunization programmes, bypassing the chances of needle stick injuries and avoiding other complications including those arising due to multiple use of single needle. As these systems improve the immune response to vaccines, eliminate risks of needles, and reduce healthcare costs, the demand for these systems has witnessed unprecedented demand. Demand for these systems has increased considerably in the recent years as they improve. However, lack of skilled professionals and the restricted use of needle-free injection systems for intravenous administration would be factors that limit the market growth.

Based on Product, the market is segmented into Fillable Needle-Free Injectors and Prefilled Needle-Free Injectors. Based on Source of Power, the market is segmented into Spring-Based Needle-Free Injectors and Gas Propelled/ Air Forced Injector Systems. Based on Type, the market is segmented into Liquid-Based Needle Free Injectors, Projectile/Depot-Based Needle-Free Injectors, and Powder-Based Needle Free Injectors. Based on Site of Delivery, the market is segmented into Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors. Based on Usability, the market is segmented into Disposable Needle-Free Injectors and Reusable Needle-Free Injectors. Based on Application, the market is segmented into Vaccine Delivery, Insulin Delivery, Pain Management, and Other Application. The report also covers geographical segmentation of Needle-free Injection Systems market. The geographies included in the report are Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the LAMEA Needle-free Injection Systems Market. Key companies profiled in the report include Endo International PLC, Antares Pharma, Inc, Pharmajet, Medical International Technology, Inc. (MIT), Injex Pharma AG, National Medical Products, Inc., Valeritas, Inc., European Pharma Group BV, Wright Medical Group, Inc., and Bioject Medical Technologies Inc.